This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amparo EG, Higgins CB, Farmer D, Gasmu G, MacNamara M (1984) Gated MRI of cardiac and paracardiac masses: initial experience. AJR 143:1151–1156
Barakos JA, Brown JJ, Higgins CB (1989) MR imaging of secondary cardiac and paracardiac lesions. AJR 153:47–50
Gomes AS, Lois JF, Child JS, Bown K, Batra P (1987) Cardiac tumors and thrombus: evaluation with MR imaging. AJR 149:895–899
Lund JT, Ehman RL, Julsrud PR, Sinak LJ, Tajik AJ (1989) Cardiac masses: assessment by MR imaging. AJR 152:469–473
Prince MR (1994) Gadolinium-enhanced MR aortography. Radiology 191:155–164
Canet E, Revel D, Forrat R et al (1993) Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. Magn Reson Med 11:1139–1145
Stillman AE et al (1996) Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 20:51–55
Stillman AE (2001) New contrast agents for cardiovascular MRI and MRA. Int J Cardiovasc Imaging 17:471–472
De Roos A, Van Rossum AC, Van der Wall EE et al (1989) Reperfused and non reperfused myocardial infarction: potential of Gd-DTPA enhanced MR imaging. Radiology 172:717–720
Pereira RS, Prato FS, Wisenberg G, Sykes J (1996) The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 36:684–693
Diesbourg LD, Proat FS, Wisemberg G et al (1992) Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modelling in canine ischemic disease. Magn Reson Med 23:239–253
Larsson HBW, Stubgaard M, Søndergaard L, Henriksen O (1994) In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 4:433–440
Kroft LJ, De Roos A (1999) Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 10:395–403
Lombardi M, Jones RA, Westby J et al (1997) MRI for the evaluation of regional myocardial perfusion in an experimental animal model. J Magn Reson Imaging 7:987–995
Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002
Wilke N, Simm C, Zhang J et al (1993) Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 29:485–497
Tombach B, Bremer C, Reimer P et al (2002) Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability. Am J Roentgenol 178:105–109
Rai AT, Hogg JP (2001) Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease. Am J Neuroradiol 22:1357–1361
Tombach B, Bremer C, Reimer P et al (2001) Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 218:651–657
Townsend RR, Cohen DL, Katholi R et al (2000) Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis 36:1207–1212
Swan SK, Lambrecht LJ, Townsend R et al (1999) Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 34:443–448
Joffe P, Thomsen HS, Meusel M (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5:491–502
Arsenault TM, King BF, Marsh JW Jr et al (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71:1150–1154
Haustein J, Niendorf HP, Krestin G et al (1992) Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27:153–156
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this chapter
Cite this chapter
Lombardi, M., Zampa, V. (2005). Contrast agents in cardiovascular magnetic resonance. In: MRI of the Heart and Vessels. Springer, Milano. https://doi.org/10.1007/88-470-0359-8_4
Download citation
DOI: https://doi.org/10.1007/88-470-0359-8_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0306-4
Online ISBN: 978-88-470-0359-0
eBook Packages: MedicineMedicine (R0)